Amgen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€247.25
Target price
02.05.26
€283.33
Performance (%)
14.20%
End price
03.05.26
€282.35
Summary
This prediction ended on 03.05.26 with a price of €282.35. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 14.20%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €9.66 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.747% | 3.747% | 26.709% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $324.00 to $320.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten